V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280006692 | 280008212 | 1.64 | null | Curative (C) | 2014-09-24 | 2014-09-29 | CARBOPLATIN + VINORELBINE | 02 | N | 280027627 | CARBO + FLUOROURACIL |
| 280006693 | 280008212 | 1.85 | 88 | null | 2018-06-26 | 2018-07-13 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 280027627 | IFOSFAMIDE |
| 280006694 | 280004092 | 1.71 | 79.1 | Palliative (P) | 2018-10-06 | 2018-10-12 | STS Rhabdo RMS 2005 Vin Cyclo | 2 | N | 280027664 | OXALIPLATIN + MDG |
| 280006695 | 280004092 | 1.63 | 60 | Palliative (P) | 2014-01-25 | 2014-02-17 | CISPLATIN + ETOPOSIDE | N | N | 280027664 | PACLITAXEL |
| 280006696 | 280004092 | 1.68 | 105.5 | Palliative (P) | 2014-09-30 | 2014-10-08 | EW EuroEwing 2012 Arm A VIDE | 2 | N | 280027664 | LIPOSOMAL DOXORUBICIN |
| 280006697 | 280004092 | null | 80.6 | Palliative (P) | 2015-02-12 | 2015-02-13 | Cyclophosphamide oral | N | N | 280027664 | PACLITAXEL |
| 280006698 | 280004092 | 1.67 | 68.8 | Palliative (P) | 2016-12-21 | 2016-12-26 | Ifosfamide | N | N | 280027664 | PACLITAXEL |
| 280006699 | 280004093 | null | 14 | Curative (C) | 2017-05-04 | 2017-05-04 | DE-ESCALATE TRIAL | N | N | 280027952 | CHOP R |
| 280006700 | 280004094 | 1.7 | 62 | null | 2014-08-13 | 2014-09-12 | Docetaxel+Gemcitabine (no prior RT) | 02 | Y | 280027997 | CARBO + FLUOROURACIL |
| 280006701 | 280008214 | null | 109.1 | Curative (C) | null | 2018-01-31 | Sunitinib | null | null | 280028043 | PATHOS TRIAL |
| 280006702 | 280008214 | 1.69 | 70 | Adjuvant (A) | 2017-10-10 | 2017-10-10 | GemCarbo Days 1+8 | 02 | N | 280028043 | PATHOS TRIAL |
| 280006703 | 280008214 | 1.71 | 75 | Palliative (P) | 2016-06-24 | 2016-07-05 | Capecitabine + Oxaliplatin 21day | 02 | Y | 280028043 | CARBOPLATIN + VINORELBINE |
| 280006704 | 280008214 | 1.55 | 71.9 | Palliative (P) | 2018-10-14 | 2018-10-28 | Capecitabine | 02 | N | 280028043 | CARBOPLATIN + VINORELBINE |
| 280006705 | 280011861 | 1.67 | 83 | Palliative (P) | 2018-02-22 | 2018-02-24 | Doxorubicin + Olaratumab | N | N | 280028523 | PACLITAXEL |
| 280006706 | 280004095 | null | 88.3 | Palliative (P) | null | 2017-08-06 | Fluorouricil + Folonic Acid (MdG) | null | null | 280028587 | CISPLATIN + ETOPOSIDE |
| 280006707 | 280004096 | 1.65 | 64.6 | Curative (C) | 2014-02-03 | 2014-02-21 | VAI (Ifos 3g/m2) | N | N | 280028689 | CISPLATIN + ETOPOSIDE |
| 280006708 | 280004096 | 1.73 | 68 | Neo-adjuvant (N) | 2013-08-23 | 2013-09-18 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 280028689 | VIDE |
| 280006709 | 280004097 | 1.75 | 38.8 | Neo-adjuvant (N) | null | 2015-01-07 | CISPLATIN + ETOPOSIDE | N | N | 280028800 | VIDE |
| 280006710 | 280004098 | 1.61 | 61.6 | Adjuvant (A) | 2017-05-18 | 2017-05-16 | Liposomal Doxorubicin (Caelyx) | 02 | N | 280028858 | CISPLATIN + DOXORUBICIN |
| 280006711 | 280004099 | 1.85 | 76.6 | Palliative (P) | null | 2017-02-14 | FLUOROURACIL + IRINOTECAN | null | null | 280028907 | DOCETAXEL + GEMCITABINE |
| 280006712 | 280004099 | 1.56 | 88.6 | Adjuvant (A) | 2017-07-04 | 2017-07-09 | Capecitabine + Cisplatin | 02 | N | 280028907 | GEMCITABINE |
| 280006713 | 280004100 | 1.65 | 100.2 | Neo-adjuvant (N) | 2016-06-10 | 2016-06-28 | Cisplatin + Vinorelbine (PO) | 02 | N | 280029078 | VIDE |
| 280006714 | 280004101 | null | null | Palliative (P) | 2015-08-26 | 2015-08-30 | Capecitabine + Oxaliplatin 21day | N | null | 280029192 | ABIRATERONE |
| 280006715 | 280004102 | null | 63.25 | null | 2014-07-11 | 2014-07-14 | Capecitabine | null | N | 280029220 | LIPOSOMAL DOXORUBICIN |
| 280006716 | 280004103 | 1.75 | 82 | Neo-adjuvant (N) | 2018-09-28 | 2018-10-25 | VIDE | 2 | N | 280029251 | ECX |
| 280006717 | 280004104 | null | null | Palliative (P) | 2019-01-03 | 2019-01-16 | Ifosfamide + Liposomal Doxorubicin | N | N | 280029354 | GEMCARBO |
| 280006718 | 280004105 | 1.79 | 54 | Palliative (P) | 2017-07-04 | 2017-07-04 | PEMBROLIZUMAB | N | N | 280029357 | IVADO |
| 280006719 | 280004105 | null | null | null | 2017-07-10 | 2017-08-05 | MELPHALAN | N | Y | 280029357 | VINORELBINE |
| 280006720 | 280004105 | 1.68 | null | Palliative (P) | null | 2015-12-08 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | N | null | 280029357 | GEDDIS TRIAL |
| 280006721 | 280004106 | 1.73 | 96.6 | Palliative (P) | null | 2017-01-16 | GemCarbo Days 1+8 | N | N | 280029448 | CARBOPLATIN + PEMETREXED |
| 280006722 | 280004106 | null | 58 | null | 2013-11-16 | 2013-11-16 | Gemcitabine + Capecitabine | N | N | 280029448 | IVADO |
| 280006723 | 280010164 | 1.73 | 89.5 | Palliative (P) | 2013-11-02 | 2013-11-06 | DOCETAXEL + GEMCITABINE | 02 | N | 280029612 | PACLITAXEL |
| 280006724 | 280004107 | 1.82 | null | Palliative (P) | 2017-02-14 | 2017-03-16 | Paclitaxel 7 day | N | Y | 280029794 | VIDE |
| 280006725 | 280004107 | 1.8 | 142.3 | Palliative (P) | 2018-05-30 | 2018-06-04 | Bortezomib + Cyclophos + Dex | N | N | 280029794 | DOCETAXEL + GEMCITABINE |
| 280006726 | 280004107 | 1.77 | 87.2 | Palliative (P) | 2013-11-13 | 2013-11-14 | Oxaliplatin + Modified de Gramont | 02 | N | 280029794 | IVA |
| 280006727 | 280011136 | 1.53 | 89.3 | null | null | 2017-05-17 | KESTREL Trial | null | null | 280029987 | IVA |
| 280006728 | 280004108 | 1.71 | 68.7 | Palliative (P) | 2018-12-29 | 2018-12-30 | Doxorubicin + Olaratumab | N | N | 280030036 | CARBOPLATIN + PEMETREXED |
| 280006729 | 280004109 | null | null | Palliative (P) | null | 2017-11-08 | Cisplatin + Vinorelbine (IV) | null | null | 280030105 | DOXORUBICIN + OLARATUMAB |
| 280006730 | 280004110 | 1.6 | 68.6 | Palliative (P) | 2015-08-24 | 2015-09-11 | Imatinib 400mg | N | N | 280030118 | CARBOPLATIN + PEMETREXED |
| 280006731 | 280004110 | 1.55 | 75.7 | Palliative (P) | 2013-11-24 | 2013-11-25 | CARBOPLATIN + GEMCITABINE | N | N | 280030118 | PACLITAXEL |
| 280006732 | 280004111 | 1.72 | 118.5 | Not known (9) | 2013-12-01 | 2014-08-11 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 280030307 | TCF |
| 280006733 | 280004112 | 1.6 | null | null | 2014-12-18 | 2014-12-19 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 280030330 | CTD |
| 280006734 | 280004113 | null | 138 | Palliative (P) | 2018-04-02 | 2018-04-06 | MCX | 02 | N | 280030348 | CYCLOPHOSPHAMIDE |
| 280006735 | 280004113 | 1.72 | 62.4 | Curative (C) | 2017-05-11 | 2017-05-16 | Cyclophosphamide oral | N | N | 280030348 | VIDE |
| 280006736 | 280004114 | null | 78.8 | Palliative (P) | 2016-09-30 | 2016-09-30 | Cisplatin + Etoposide (3 day) | null | null | 280030427 | CETUXIMAB + CISPLATIN + FU |
| 280006737 | 280004115 | 1.59 | 59.8 | null | 2018-08-30 | 2018-09-11 | CHOP R - 21 days | 1 | N | 280030458 | CYCLOPHOSPHAMIDE |
| 280006738 | 280004115 | 1.56 | null | Palliative (P) | 2017-12-19 | 2018-01-08 | CAPECITABINE + GEMCITABINE | N | N | 280030458 | DOCETAXEL + GEMCITABINE |
| 280006739 | 280004116 | 1.7 | 71.4 | Not known (9) | 2016-11-04 | 2016-12-23 | GemCarbo Days 1+8 | N | N | 280030585 | EURO-EWING |
| 280006740 | 280004116 | 1.66 | 71 | Adjuvant (A) | 2018-02-06 | 2018-02-24 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 280030585 | RITUXIMAB |
| 280006741 | 280004116 | 1.72 | 86 | Curative (C) | 2014-05-23 | 2014-06-07 | Liposomal Doxorubicin (Caelyx) | N | N | 280030585 | RMS 2005 TRIAL |